Clinical Trials

490 enrolled

Prostatic Neoplasms

NCT05435495 2026-03-18

Mechanisms of Resistance to PSMA Radioligand Therapy

125 enrolled

BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasm

Prostatic Neoplasms

NCT07328516 2026-03-18

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Enrolling by invitation

64,277 enrolled

Breast Neoplasms, Leukemia, Melanoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT07428642 2026-03-18

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

Completed

168 enrolled

Prostatic Neoplasms

NCT06868927 2026-03-17

TARGET-RCC

50 enrolled

Carcinoma, Renal Cell

NCT06973161 2026-03-17

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

GastrointestinalGenitourinaryGynecologicThoracic

105 enrolled

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07300631 2026-03-17

OASIS

320 enrolled

Prostate Cancer Patients Treated by Radiotherapy

NCT07478536 2026-03-17

CHAS3

Not yet recruiting

350 enrolled

Neoplasms, Prostatic Neoplasms

NCT00001238 2026-03-16

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

5,000 enrolled

EndocrineGenitourinary

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, Kidney Neoplasms, Pheochromocytoma

NCT02121730 2026-03-16

FRISC

Completed

2,500 enrolled

Kidney Neoplasms, Neoplasms

NCT05102110 2026-03-16

ORI-EGI-03

GastrointestinalGenitourinaryThoracic

450 enrolled

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT06109857 2026-03-16

Bladder Bank (a Prospective Banking Study)

1,500 enrolled

Urinary Bladder Neoplasms

NCT07465458 2026-03-16

RASROP-003

Not yet recruiting

226 enrolled

Carcinoma, Renal Cell

NCT07468838 2026-03-16

UroDNA

Not yet recruiting

25 enrolled

GenitourinaryLymphoidOther hematologic neoplasm

Urinary Bladder Neoplasms, Prostatic Neoplasms

NCT07474051 2026-03-16

PERSIST

Enrolling by invitation

178 enrolled

Prostatic Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT07474142 2026-03-16

PSMA-VISION

1,000 enrolled

Prostatic Neoplasms

NCT03996850 2026-03-13

SPECT/CT for the Characterization of Renal Masses

102 enrolled

Kidney Neoplasms

NCT04788277 2026-03-13

Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)

675 enrolled

Prostatic Neoplasms

NCT05901649 2026-03-13

ArtemisPRO

504 enrolled

Metastatic Hormone-sensitive Prostate Cancer

NCT07309445 2026-03-13

Nova-sTAR

150 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04435756 2026-03-12

A Study of miRNA 371 in Patients With Germ Cell Tumors

956 enrolled

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Seminoma

NCT04706481 2026-03-12

Archival of Human Biological Samples in CU-Med Biobank

10,000 enrolled

Diabetes Mellitus, Disease, Heart Diseases, Kidney Diseases, Neoplasms

NCT06334120 2026-03-12

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

600 enrolled

Non-metastatic Castration-resistant Prostate Cancer

NCT06349642 2026-03-12

ELEPHAS-04